Tigermed-Jyton

Innovative Device R&D Integration Service Plat

Service Creates Value

ABOUT

Tigermed-Jyton

Tigermed-Jyton, a wholly-owned subsidiary of Tigermed Group (Stock code: 300347.SZ/3347.HK), was established in 2000, and is a leading CRO service provider in China for regulatory affairs and clinical research of medical devices (including in vitro diagnostic products), with service covering the whole life cycle of all fields of medical devices. In the past 20 years, we have established long-term cooperative relations with more than 1,700 medical device R&D and manufacture enterprises from more than 30 countries. With our professional service capability, we can reduce registration risk, shorten project timeline, save R&D funds and accelerate the process of product marketization.


Learn More

Professional Solutions for Medical Devices

Providing Full Lifecycle Services

In China For Global

5300+

Clinical Trial Service projects

400+

Medical Writing Experience

330+

IVD Service projects

Serving more than 1,400 medical device R&D and manufacturing companies in more than 30 countries around the world.

News

Tigermed-Jyton Accelerates Approval of China’s First Full Magnetic Suspension Artificial Heart—New Hope for Patients with Advanced Heart Failure
Tigermed-Jyton Accelerates Approval of China’s First Full M···

Recently, NationalMedical Products Administration (NMPA) approved the registrati···

Tigermed-Jyton and Reunion Reached Strategic Cooperation to Jointly Promote R&D of High-Quality Medical Devices
Tigermed-Jyton and Reunion Reached Strategic Cooperation to ···

The signing ceremony for strategic cooperation between Shanghai Reunion Biotechn···

TOP